Arkolith/Insider Trading/CHRO/Form 4/A

Friedberg Ezra M

DirectorChromocell Therapeutics Corp (CHRO) · full profile →Form 4/A · filed Mar 12, 2024
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 21, 2024Buy(P)17K$6.00$100K546K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001753926-24-000518) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML